APAC and MENA Prefilled Syringes Market to Hit $6.13 Billion by 2033 | Key Players - BD, Terumo Corporation, Sanofi S.A., Hikma Pharmaceuticals PLC

Leander, Texas and Tokyo, Japan - Dec.11.2025
As per DataM intelligence research report" The APAC and MENA prefilled syringes market size reached US$ 2.28 billion in 2024 and is expected to reach US$ 6.13 billion by 2033, growing at a CAGR of 12.0% during the forecast period 2025-2033." Biologics expansion and patient-centric drug delivery are boosting prefilled syringe adoption across both regions.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/apac-and-mena-prefilled-syringes-market?Prasad

Asia Pacific: Recent Industry Developments

✅ In November 2025, Terumo Corporation expanded its prefilled syringe production in Vietnam The expansion serves the growing demand for vaccines and biologics in Southeast Asia It establishes a regional manufacturing hub for high-quality delivery systems

✅ In October 2025, A Chinese glass manufacturer launched a break-resistant prefilled syringe The innovation addresses transport durability issues in the vast Chinese market It improves the safety of drug distribution in APAC

✅ In September 2025, Biocon Biologics (India) launched a biosimilar insulin in a prefilled pen The convenient device aims to improve diabetes management in developing Asian countries It increases access to affordable insulin delivery

✅ In August 2025, Samsung Biologics announced plans to add fill-finish capacity for prefilled syringes The investment supports their CDMO clients launching products in the Asian market It strengthens South Korea's position in biopharma manufacturing

Middle East & Africa: Recent Industry Developments

✅ In December 2025, Julphar (UAE) inaugurated a new line for filling prefilled syringes The line is dedicated to producing enoxaparin and other critical injectables It boosts the local production of essential medicines in the GCC

✅ In November 2025, Egypt signed a technology transfer deal to manufacture prefilled vaccines The deal aims to make Egypt a vaccine hub for the African continent It enhances health security in the MENA region

✅ In October 2025, A Saudi pharma company launched a prefilled syringe of a biosimilar autoimmune drug The launch provides a cost-effective alternative to imported biologics It supports the localization goals of the Saudi healthcare system

✅ In September 2025, Gerresheimer partnered with a local distributor to supply syringe barrels to MENA manufacturers The partnership ensures the availability of high-quality primary packaging It supports the growth of the regional injectables industry

APAC and MENA Prefilled Syringes Market: Drivers
Prefilled syringes in APAC and MENA are gaining popularity for safe, convenient, and accurate drug administration, particularly in biologics, vaccines, and specialty therapeutics. Benefits include reduced dosing errors, contamination risk, and enhanced patient adherence. Innovations in polymer syringes, autoinjectors, and safety-engineered designs improve usability and compliance.

Market growth is driven by expanding immunization programs, biologic drug adoption, and hospital infrastructure improvements. Manufacturers invest in quality assurance, regulatory approvals, and supply chain efficiency. Prefilled syringes are critical for streamlining drug delivery, enhancing patient safety, and supporting regional healthcare modernization initiatives.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/apac-and-mena-prefilled-syringes-market?Prasad

APAC and MENA Prefilled Syringes Market: Major Players
BD, Terumo Corporation, Sanofi S.A., Hikma Pharmaceuticals PLC, Cardinal Health, Nipro Corporation, and B. Braun SE among others.

Segment Covered in the APAC and MENA Prefilled Syringes Market:
By Product Type
The market is segmented into glass prefilled syringes 55% and plastic prefilled syringes 45%. Glass syringes dominate due to chemical inertness, high stability, and suitability for biologics and vaccines. Plastic syringes grow steadily with advantages in safety, reduced breakage, and cost-effectiveness. Rising biologic drug adoption and vaccination programs drive demand for both types across APAC and MENA.

By Therapeutic Area
Therapeutic areas include vaccines 40%, biologics 30%, oncology 15%, diabetes 10%, and others 5%. Vaccines dominate due to mass immunization programs and preventive healthcare initiatives. Biologics adoption grows with increasing chronic and autoimmune disease management. Oncology and diabetes applications see steady growth driven by self-administration trends and patient convenience.

By End-User
End-users include hospitals 50%, clinics 30%, and home care 20%. Hospitals dominate due to large-scale immunization and biologic administration. Clinics grow steadily with outpatient treatments and specialty therapies. Home care adoption rises with patient-centric care models, self-injection therapies, and convenience-focused delivery solutions. Regulatory support and healthcare infrastructure improvements drive overall adoption.

Regional Analysis
Asia Pacific - 65% Share
APAC leads with 65% share due to high population, extensive vaccination programs, and growing biologics market. Glass syringes dominate. Hospitals and clinics are primary end-users. Expanding healthcare infrastructure, government immunization campaigns, and pharmaceutical manufacturing hubs in China, India, Japan, and South Korea support market growth.

Middle East & Africa - 35% Share
MEA accounts for 35% share with growing adoption in UAE, Saudi Arabia, South Africa, and Egypt. Glass and plastic syringes are both used. Hospitals and clinics dominate administration. Increasing vaccination initiatives, biologics adoption, and government healthcare investments drive regional market penetration.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=apac-and-mena-prefilled-syringes-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?Prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.